Session » Rheumatoid Arthritis – Clinical Aspects IV: Managing Patients in Remission
-
Abstract Number: 3011
Long-Term Outcomes after Disease Activity Guided Tapering of Tumor Necrosis Factor Inhibition in Rheumatoid Arthritis: 3 Year Data of a Randomised Controlled Pragmatic Non Inferiority Strategy Study
-
Abstract Number: 3013
Dose Reduction or Discontinuation of Biological Therapy in Patients with Rheumatoid Arthritis in Remission – 1-Year Results of a Guideline-Directed Longitudinal Cohort Study
-
Abstract Number: 3014
Tapering of Adalimumab Based on Therapeutic Drug Monitoring in Rheumatoid Arthritis
-
Abstract Number: 3015
The Good, the Bad and the Ugly – Refractory Rheumatoid Arthritis in 2016